| Gambino Eye Associates, Inc. | |
|
4150 Belt Line Rd, Ste 200, Addison, TX 75001-4354 | |
| (972) 386-9646 | |
| Not Available |
| Full Name | Gambino Eye Associates, Inc. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 4150 Belt Line Rd, Addison, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053588780 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4387T (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gambino Eye Associates, Inc. 4150 Belt Line Rd, Ste 200, Addison, TX 75001-4354 Ph: (972) 386-9646 | Gambino Eye Associates, Inc. 4150 Belt Line Rd, Ste 200, Addison, TX 75001-4354 Ph: (972) 386-9646 |
News Archive
A new, first-of-its-kind study led by researchers from Boston College has found that personal networks in India could play an important role in advancing the adoption of a cleaner cooking fuel, in this case liquefied petroleum gas, according to a report published in the journal Environmental Research Letters.
A University of California, Riverside, study that sought to determine barriers to health care among Spanish-speaking Latino farmworkers in rural communities has devised an innovative health care service delivery model that addresses many challenges these communities face.
Claros Diagnostics, a developer of novel point-of-care in vitro diagnostic systems, today announced the CE Mark approval for its rapid quantitative point-of-care diagnostic platform, which can now be used for prostate specific antigen (PSA) testing throughout the European Union. The approved system consists of a small portable analyzer and credit card-sized disposable.
An international research team, supported by the National Institutes of Health (NIH), today announced it has completed a high-quality, draft sequence of the genome of the laboratory rat, and has used that data to explore how the rat's genetic blueprint stacks up against those of mice and humans.
Cempra Pharmaceuticals today announced that enrollment is underway in an adaptive design Phase 2/3 clinical study with CEM-102 for patients suffering from acute bacterial skin structure infections (ABSSI). CEM-102 is an oral antibiotic with an established record of treating staphylococcal infections outside the United States, including those due to methicillin-resistant Staphylococcus aureus (MRSA).
› Verified 6 days ago
Premier Vision Of Dallas Optometrist Medicare: Not Enrolled in Medicare Practice Location: 16479 Dallas Pkwy, Suite 475, Addison, TX 75001 Phone: 214-562-6290 | |
Steven Charles Kurtin, DO Optometrist Medicare: Accepting Medicare Assignments Practice Location: 17051 N. Dallas Parkway #175, Addison, TX 75001 Phone: 972-908-9999 | |
Dr. Michel Joseph Gambino Iii, O. D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4150 Belt Line Rd, Addison, TX 75001 Phone: 972-386-9646 Fax: 972-386-3371 |